ELEVANCE HEALTH, INC. (ELV) FY2026 Q2 Balance Sheet

ELEVANCE HEALTH, INC. (ELV) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

126,438,000,000 US dollars

Current assets

67,184,000,000 US dollars

Non-current assets

59,254,000,000 US dollars

Liabilities

81,416,000,000 US dollars

Current liabilities

44,254,000,000 US dollars

Non-current liabilities

37,162,000,000 US dollars

Equity

45,022,000,000 US dollars

Noncontrolling interest

139,000,000 US dollars. Included in consolidated equity; this amount is not added again.

Fixed maturity securities (amortized cost of $25,962 and $25,773; allowance for credit losses of $55 and $21)

25,719,000,000 US dollars

Premium receivables, net

10,991,000,000 US dollars

Cash and cash equivalents

10,232,000,000 US dollars

Other receivables

6,818,000,000 US dollars

Other current assets

6,278,000,000 US dollars

Self-funded receivables, net

5,583,000,000 US dollars

Equity securities

1,563,000,000 US dollars

Goodwill

28,339,000,000 US dollars

Other invested assets

11,130,000,000 US dollars

Other intangible assets

10,983,000,000 US dollars

Property and equipment, net

4,645,000,000 US dollars

Other noncurrent assets

2,898,000,000 US dollars

Fixed maturity securities (amortized cost of $1,263 and $1,116; allowance for credit losses of $$0 and $0)

1,259,000,000 US dollars

Medical claims payable

18,463,000,000 US dollars

Other current liabilities

13,681,000,000 US dollars

Accounts payable and accrued expenses

6,632,000,000 US dollars

Other policyholder liabilities

3,463,000,000 US dollars

Unearned income

1,640,000,000 US dollars

Current portion of long-term debt

375,000,000 US dollars

Short-term borrowings

0 US dollars

Long-term debt, less current portion

30,669,000,000 US dollars

Other noncurrent liabilities

4,287,000,000 US dollars

Deferred tax liabilities, net

2,206,000,000 US dollars

Retained earnings

36,675,000,000 US dollars

Additional paid-in capital

8,917,000,000 US dollars

Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding – 216,841,146 and 220,723,898

2,000,000 US dollars

Preferred stock, without par value, shares authorized 100,000,000; shares issued and outstanding – none

0 US dollars

Noncontrolling interests

139,000,000 US dollars

Accumulated other comprehensive loss

negative 711,000,000 US dollars

Gross equity (calculated)

45,733,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.